APA (7th ed.) Citation

Colacci, M., Raudanskis, A., & Fralick, M. (2025). Response to letter to the editor by Lai-Ming Kathleen Pak et al on: Identifying predictors of SGLT2 inhibitor and GLP1R agonist use in hospital among adults with diabetes. Journal of Diabetes & its Complications, 39(10), N.PAG. https://doi.org/10.1016/j.jdiacomp.2025.109046

Chicago Style (17th ed.) Citation

Colacci, Michael, Ashley Raudanskis, and Michael Fralick. "Response to Letter to the Editor by Lai-Ming Kathleen Pak Et Al on: Identifying Predictors of SGLT2 Inhibitor and GLP1R Agonist Use in Hospital Among Adults with Diabetes." Journal of Diabetes & Its Complications 39, no. 10 (2025): N.PAG. https://doi.org/10.1016/j.jdiacomp.2025.109046.

MLA (9th ed.) Citation

Colacci, Michael, et al. "Response to Letter to the Editor by Lai-Ming Kathleen Pak Et Al on: Identifying Predictors of SGLT2 Inhibitor and GLP1R Agonist Use in Hospital Among Adults with Diabetes." Journal of Diabetes & Its Complications, vol. 39, no. 10, 2025, p. N.PAG, https://doi.org/10.1016/j.jdiacomp.2025.109046.